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Results: On macroscopic examination 47 knees had normal, 36 abnormal
and 12 ruptured ACLs. ACL histological scores for collagen degeneration
and the number of blood vessels increased with aging. We compared
with summed cartilage scores to determine the relationship between ACL
and cartilage degeneration. There was a positive correlation between ACL
scores and total, trochlear and medial but not with lateral cartilage scores.
Increased MMP-3 and CD45 expression in ACLs correlated with ACL de-
generation score especially in the gaps between fascicles and in the cell
inﬁltrates around blood vessels.
Conclusions: ACL degeneration correlates with cartilage degeneration,
especially in the medial compartment of the knee joint. This suggests
that ACL deﬁciencies contribute not only to posttraumatic OA but also to
aging-related development of cartilage degradation and OA pathogenesis.
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SINGLE INTRA-ARTICULAR INJECTION RESULTS IN STABLE AND
CONTROLLABLE IN VIVO TRANSGENE EXPRESSION
K.A. Payne1, H.H. Lee1, A.M. Haleem1, C. Martin1, X. Xiao2, C.R. Chu1
1Univ. of Pittsburgh, Pittsburgh, PA; 2Univ. of North Carolina, Chapel Hill, NC
Purpose: To test the hypothesis that in vivo transgene expression mediated
by adeno-associated virus serotype 2 (AAV2) following single intra-articular
injection of AAV is: (1) localized to the injected joint, (2) persists through
one year after injection, and (3) can be externally controlled.
Methods: Nine male Sprague-Dawley (SD) rats received AAV2-CMV-GFP
and AAV2-CMV-Luciferase (Luc) into their right and left knees, respectively.
Luciferase expression was evaluated over a 1-year period using the IVIS®
Imaging System (Xenogen). After sacriﬁce, tissues within the joint were
analyzed by ﬂuorescence stereomicroscopy to detect GFP+ cells. To study
the ability to control AAV transgene expression in the rat knee joint, an
additional ﬁve male SD rats received AAV2-tetracycline response element
(TRE)-Luc and AAV2-CMV-transcriptional transactivator into the right knee,
and AAV2-CMV-Luc into the left knee. To induce expression of luciferase, 2
mg/ml doxycycline (Dox) was added to the drinking water, and rats were
imaged twice a week as described above.
Results: Luciferase expression was detectable in all rats post-injection.
Long-term rats showed continued and stable luciferase expression through
1 year. GFP+ cells were mainly found in the intra-articular soft tissues
surrounding the articular cartilage, with rare GFP+ chondrocytes. For the
joints injected with inducible AAV-TRE-Luc, gene expression was upregu-
lated (p<0.05) after addition of Dox, and downregulated (p<0.05) following
removal of Dox.
Conclusions: Longitudinal in vivo results show persistent and stable
AAV-mediated gene expression through one year following a single intra-
articular injection. The use of inducible TRE promoter allows the feasibility
to control in vivo transgene expression in the rat knee joint. These results
suggest that AAV is a potential therapeutic approach to deliver growth
factors in the knee joint persistently in a time-controlled manner. The
rare occurrence of GFP+ cells in intact articular cartilage indicates that
more studies on AAV delivery to damaged articular cartilage, which can
progress to osteoarthritis, are needed. This continued characterization of
the length, location and ability to control transgene expression following
intra-articular injection of AAV will help to better tailor gene therapy
for articular cartilage repair, which may delay or prevent the onset of
osteoarthritis.
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VEGF 111 AS A NEW THERAPEUTIC TOOL FOR TENDON LESION
J.-F. Kaux1, P. Drion1, V. Libertiaux1, F. Pascon1, A. Colige1, C. Le Goff1,
C. Lambert1, B. Nusgens1, A. Gothot1, S. Cescotto1, J.-O. Defraigne1,
M. Rickert2, J.-M. Crielaard1
1Univ. of Liège, Liège, Belgium; 2Univ. of Heidelberg, Heidelberg, Germany
Purpose: Tendon lesion is one of the most frequent pathology in sports and
by physical workers. This pathology often becomes chronic. For this reason,
it is of interest to develop new treatments. Injection of platelet-rich plasma
(PRP) seems to be a promising one by releasing growth factors (GF) locally.
Among all the GF released by activated platelets, the vascular endothelial
growth factor-A (VEGF-A) is known to induce positive effects on vascular
function and angiogenesis, and could be implicated in the healing process
of tendons. Recently, a novel VEGF-A isoform was identiﬁed, the VEGF-111,
a biologically active and proteolysis-resistant VEGF-A isoform, also known
to present beneﬁcial effects on ischemic diseases. This prompted us to
evaluate whether VEFF-111 would have a therapeutic interest within the
framework of the tendon pathology.
Methods: 60 Rats were divided into 2 groups: A: control (no injection), B:
VEGF-111 treatment. A 5mm defect was surgically induced in rat Achilles
tendon after resection of plantaris tendon. Rats received a local injection of
VEGF-111 (100ng) in situ after the surgery and were placed in their cages
without immobilization. After 5, 15 and 30 days, the traumatized Achilles
tendons of 10 rats of both groups were removed and dissected during their
healing process. Immediately after sampling, tendons were submitted to
a biomechanical tensile test up to rupture, using a “Cryo-jaw”. Rats were
then euthanized.
Statistical analyses were made with an ANOVA. Values are signiﬁcant when
p-value is below 0.05.
Results: Our results shown that the developed force necessary to induce
tendon rupture during biomechanical tensile test was greater for tendons
which had received an injection of 100ng of VEGF-111. These results were
already noticed from day 5 onwards. The ratio between force and weight
increased with time in both groups, but this ratio was greater for tendons
which had been submitted to an injection of VEGF111. The surface area of
the section of the tendons increased between 5 and 15 days followed by
a stabilization. After 30 days, sections in both groups were similar. Thus,
the constraint was similar after 5 and 15 days but was better for VEGF111
group after one month.
Conclusions: This experimentation has shown that a 100ng injection of
VEGF-111 stimulated tendon healing process as suggested by the increased
force needed to break tendons during its healing process and the increased
of constraint in comparison with the control group. Other experimentations
with different concentration of VEGF111 are now in process.
Acknowledgement: This experimentation was partially ﬁnanced by “Stan-
dard de Liège 2007” and “Lejeune-Lechien 2008” grants.
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METALLOPROTEINASE EXPRESSION AND ACTIVITY IN THE MENISCUS:
IMPLICATIONS FOR THE PATHOGENESIS OF OA
E.S. Fuller, M.M. Smith, C.B. Little, J. Melrose
Kolling Inst. of Med. Res., Sydney, Australia
Introduction: Meniscal degeneration is a signiﬁcant prognostic factor in
progressive cartilage loss in symptomatic knee osteoarthritis (OA). Despite
this, relatively little is known about the mechanisms of meniscal degener-
ation and whether this differs from articular cartilage (AC). The meniscus
has distinct zones, the inner ∼1/3rd being avascular and ﬁbrocartilaginous
while the outer region is vascular and more ﬁbrous. Recent studies have
examined meniscal degeneration in vitro using explant cultures but have
not directly compared the inner versus outer zones and with AC.
Methods: Ovine AC and inner and outer zone meniscal explants were
dissected from the same joints, and cultured separately for 4 days in
serum free media ± IL-1α (10ng/ml) or TNFα (100ng/ml); n≥6 for all treat-
ments. Matrix metabolism and enzyme activity were assessed by sulphated
glycosaminoglycan (GAG) and collagen (hydroxyproline) release, qRT-PCR
(aggrecan; collagen I & II; MMP-1, -2, -3, -9, -13, & -14; TIMP-1 & -3),
aggrecan neoepitope Western blotting, gelatin zymography, and MMP-13
substrate assay. Only differences where p < 0.05 are reported.
Results: Both meniscal zones had higher GAG release (% total) than AC
in control and cytokine treated cultures. Inner meniscus was similar to
AC with a signiﬁcant increase in GAG release after both cytokines; outer
meniscus showed less response and only to IL-1α. The outer meniscus
was unique in releasing signiﬁcant collagen following cytokine stimu-
lation. Aggrecan loss in control meniscal cultures was associated with
ADAMTS-cleavage (increased NITEGE compared to ex-vivo). IL-1α- and
TNFα-stimulated aggrecan loss in AC and inner meniscus was associated
with increased NITEGE, while cleavage by MMPs (increased DIPEN) pre-
dominated in outer meniscus. Expression of aggrecan, collagen I & II
ex-vivo reﬂected tissue compositions. Aggrecan and collagen mRNA were
decreased in all tissues by IL-1α and TNFα. ADAMTS-5 mRNA was increased
compared with ex-vivo in control meniscal but not AC cultures. IL-1α and
TNFα increased ADAMTS-4 & ADAMTS-5 expression in the meniscus more
than AC, with ADAMTS-4 more responsive to IL-1α and ADAMTS-5 to TNF.
MMP-1, -3, -9, -13 & -14 expression increased in both meniscal zones with
IL-1α and TNFα, while MMP-2 only increased in the outer zone. In contrast,
only MMP-1 and -3 were signiﬁcantly increased by cytokines in AC, and
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expression of all MMPs was greater in meniscus than AC. In general MMP
expression in the outer meniscus was more responsive to TNFα. TIMP-1
and -3 were generally decreased in all tissues by IL-1α and TNFα. There
was more pro and active MMP-2, and pro-MMP-13 in control cultures of
outer meniscus than AC or inner meniscus. Unlike AC, both meniscal zones
released active MMP-13 after IL-1α and TNFα treatment, and active MMP-2
after IL-1α (inner) or both cytokines (outer).
Conclusions: Aggrecan processing differed between outer versus inner
meniscus, with the later being similar to AC. Aggrecan proteolysis in the
outer meniscus rather than AC, may be responsible for MMP-generated
neoepitopes detected in OA human knee synovial ﬂuid. The meniscus
was generally more responsive to TNFα than AC, particularly the outer
zone. Expression of MMPs and ADAMTS was higher in meniscus than AC,
and unlike AC active MMPs were released from meniscus. The meniscus
may contribute signiﬁcantly to metalloproteinase levels in the joint, and
therefore to cartilage breakdown in OA. Differential regulation of MMPs
and ADAMTS in the knee joint meniscus compared with AC, and between
inner and outer meniscal zones has important implications in OA therapy.
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EFFECTS OF FEEDING A HIGH OMEGA-3 FATTY ACID DIET ON THE
PAIN-RELATED DISABILITY IN DOGS WITH NATURALLY OCCURRING
OSTEOARTHRITIS
M. Moreau, É. Troncy, D. Gauvin, B. Lussier
Université de Montréal, St-Hyacinthe, QC, Canada
Purpose: Lameness associated with osteoarthritis (OA) is highly prevalent
in dogs. Typically, OA dogs have a decrease in their limb function, demon-
strate discomfort and disability with an unwillingness to perform daily life
activities. To alleviate those clinical signs, management of OA based on
diet enriched in polyunsaturated omega-3 fatty acids (omega-3 PUFAs) is
broadly considered by clinicians despite the lack of published clinical trials
supporting their eﬃcacy. The aim of this study was to measure functional
outcomes in lame client-owned dogs aﬄicted by naturally occurring OA
before and after a 13 week period of feeding with either a control diet (CTR)
or a veterinary therapeutic diet (VTD) containing high levels of omega-3
PUFAs. Hypothetically, the functional outcomes would be signiﬁcantly
improved from Baseline only in VTD-treated dogs. The magnitude of those
changes would exceed CTR-treated dogs.
Methods: A randomized, double-blinded, placebo-controlled trial was per-
formed in 45 lame client-owned dogs with OA. Dogs were included in
the study when they had hind limb lameness observed by a veterinary
surgeon, signs of OA upon orthopedic examination and low dynamic weight
bearing (peak vertical force, PVF) recorded on force platform gait analysis.
The presence of OA was conﬁrmed on radiographs (hip and/or stiﬂe). The
initial condition (Baseline) of dogs was determined by the recording of
PVF (primary study outcome) and by client-speciﬁc outcome measures
(CSOM). Dogs were randomly allocated to 3 groups (15/group) and received
a control diet (CTR1 or CTR2) or the therapeutic VTD diet. Assessment by
CSOM was performed twice weekly by the owner, and PVF was repeated
after 13 weeks of treatment. Statistical analyses were performed using
nonparametric tests at p<0.05.
Results: Median PVF values increased signiﬁcantly in VTD-treated dogs
(+9.4%, p=0.049). Neither CTR1- (+2.4%,p=0.582) nor CTR2-treated (+2.6%,
p=0.187) dogs revealed such signiﬁcant improvement. In addition, at week
13, CSOM assessment denoted a signiﬁcant decrease in score (meaning
improvement) for VTD-treated dogs (-20%, p=0.021), but not for CTR1 (0%,
p=0.216) or CTR2 (-5.8%, p=0.267). The magnitude of the changes of PVF and
CSOM in VTD-treated dogs was not signiﬁcantly different from CTR-treated
dogs.
Conclusions: The use of a high quality diet and good nutritional habits
may have prompted the monitoring of a trend toward a better function
in CTR dogs, despite the absence of omega-3 PUFAs in these control
diets. Nutrition-based OA management improved functional outcome and
performance in daily life activities when dogs were fed with VTD over a
short-term period. This veterinary diet containing omega-3 PUFAs should
be considered as a therapeutic modality to alleviate the clinical signs in
dogs aﬄicted by OA as a unique treatment or as part of a multimodal
approach in the management of OA.
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CENTRAL SENSITIZATION IN KNEE OA: PRELIMINARY RESULTS FROM THE
MOST STUDY
T. Neogi1, J. Niu1, L. Arendt-Nielsen2, J. Scholz3, L. Frey-Law4, C. Woolf3,
Y. Zhang1, L. Bradley5, M. Nevitt6, D. Felson1
1BUSM, Boston, MA; 2Univ. of Aalborg, Aalborg, Denmark; 3Childrens Hosp.,
Boston, MA; 4UIowa, Iowa City, MA; 5UAB, Birmingham, AL; 6UCSF, San
Francisco, CA
Purpose: Mechanisms contributing to knee pain in osteoarthritis (OA) are
not well understood. Mechanical and inﬂammatory stimuli in the joint may
lead both to changes in the peripheral threshold of nociceptors (peripheral
sensitization) and a central ampliﬁcation of signals in the CNS (central
sensitization), resulting in heightened pain sensitivity. We hypothesized
that knee OA, particularly OA severity and duration, may be associated with
central sensitization. We therefore examined whether knee OA was associ-
ated with temporal summation, an augmented pain response to repetitive
mechanical stimuli that indicates the presence of central sensitization.
Methods: The Multicenter Osteoarthritis (MOST) Study is cohort study of
persons with or at high risk of knee OA. Participants underwent knee
radiography at baseline, 30, and 60 months. At 60 months we carried out
an evaluation of temporal summation using a 60g monoﬁlament at the
wrist and separately over each patella. Temporal summation was deﬁned
as being present when, after touching the skin with the monoﬁlament
repeatedly at a frequency of 1Hz for 30 seconds, the subject reported new
pain or increased pain at the site being tested. Persons were categorized by
number of knees (0, 1 or 2) with OA at 60 months (OA deﬁned on x-ray by
KL≥2). Knees were categorized according to KL grade, OA presence and OA
duration. We examined the relation between OA (presence, severity, dura-
tion) with temporal summation cross-sectionally using Poisson regression
for person-based analyses and with GEE for knee based-analyses, adjusting
for potential confounders. We also used a within-person knee-matched
approach among persons with knees discordant for temporal summation to
explore these relationships while eliminating between-person confounding
using matched conditional logistic regression.
Results: To date, data on 920 participants’ 60-month clinic visit are
available (mean age 68.0, mean BMI 30.8, 67.3% female). The age- and
sex-adjusted prevalences of temporal summation at the wrist among
persons with 0, 1 and 2 knees with OA were 55%, 53%, 57%, and at
either patella were 61%, 56%, 63%, respectively. Persons with 1 and 2
knees with OA were 0.85 and 1.09 times as likely to have temporal
summation at the wrist (95% CI 0.59-1.22 and 0.78-1.54, respectively),
and 0.74 and 1.04 times as likely to have temporal summation at either
patella, respectively (95% CI 0.51-1.06 and 0.73-1.48, respectively), than
persons with no knee OA. In knee-based analyses, OA presence, severity
and duration were not associated with presence of temporal summation
at the patella. For example, presence of knee OA was associated with 1.16
times higher prevalence of temporal summation compared with no OA
(95% CI 0.91-1.49). However, in the within-person knee-matched analyses,
knee OA was associated with 2.30 times higher prevalence of temporal
summation than no OA (95% CI 1.10-4.83). Further, knees with KL grade
≥3 had 2.80 times higher prevalence of temporal summation than knees
with KL grade 0 (95% CI 1.06-7.40). Even among knees with some degree of
radiographic abnormality, those with KL grade ≥2 had a higher prevalence
of temporal summation than those with KL grade 1 (prevalence ratio (PR)
1.59, 95% CI 1.01-2.52). Knees with a longer duration of OA also had higher
prevalence of temporal summation than those without any OA (PR 2.56,
95% CI 1.03-6.37).
Conclusions: In these preliminary results from a large cohort, the presence,
severity and duration of OA were associated with temporal summation
when between-person confounding could be adequately controlled for.
Such ﬁndings suggest that severity and chronicity of pathology are as-
sociated with central sensitization. Future work will include longitudinal
evaluation of central sensitization and its manifestations in OA.
